Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Olivier Geneste
Observed names:
Geneste\t, Olivier,
O Geneste,
O. Geneste,
Olivier GENESTE
Observed institutions:
Lyon 1 Université,
Centre National de la Recherche Scientifique,
Cancer Research UK,
Servier (France),
Pierre Fabre (France),
Centre international de recherche sur le cancer,
Novartis Institutes for BioMedical Research,
Institut de Recherches Internationales Servier (France)
show all 8
OpenAlex ID:
A5108684212
Functional and physical interaction between Bcl‐XL and a BH3‐like domain in Beclin‐1
2007
·
M Chiara Maiuri
, Gaëtane Le Toumelin
, et al.
·
The EMBO Journal
·
1,154
PDF
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
2016
·
András Kotschy
, Zoltán Szlavik
, et al.
·
Nature
·
1,075
BH3-Only Proteins and BH3 Mimetics Induce Autophagy by Competitively Disrupting the Interaction between Beclin 1 and Bcl-2/Bcl-XL
2007
·
Maria Chiara Maiuri
, Alfredo Criollo
, et al.
·
Autophagy
·
448
PDF
Decoding and unlocking the BCL-2 dependency of cancer cells
2013
·
Philippe Juin
, Olivier Geneste
, et al.
·
Nature reviews. Cancer
·
254
Activation of SRF-Regulated Chromosomal Templates by Rho-Family GTPases Requires a Signal that Also Induces H4 Hyperacetylation
1998
·
Arthur S Alberts
, Olivier Geneste
, et al.
·
Cell
·
227
PDF
An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity.
1992
·
K Alexandrov
, M Rojas
, et al.
·
PubMed
·
212
LIM kinase and Diaphanous cooperate to regulate serum response factor and actin dynamics
2002
·
Olivier Geneste
, John W. Copeland
, et al.
·
The Journal of Cell Biology
·
207
PDF
Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer
2017
·
Delphine Merino
, James R. Whittle
, et al.
·
Science Translational Medicine
·
195
Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia
2018
·
Donia M. Moujalled
, Giovanna Pomilio
, et al.
·
Leukemia
·
176
PDF
Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members
2009
·
Tristan Gallenne
, Fabien Gautier
, et al.
·
The Journal of Cell Biology
·
153
High variability of nitrosamine metabolism among individuals: Role of cytochromes P450 2A6 and 2E1 in the dealkylation of N‐nitrosodimethylamine and N‐nitrosodiethylamine in mice and humans
1993
·
Anne‐Marie Camus
, Olivier Geneste
, et al.
·
Molecular Carcinogenesis
·
147
The Small Organic Compound HA14-1 Prevents Bcl-2 Interaction with Bax to Sensitize Malignant Glioma Cells to Induction of Cell Death
2006
·
Florence Manero
, Fabien Gautier
, et al.
·
Cancer Research
·
135
PDF
Cell Cycle-Dependent Induction of Autophagy, Mitophagy and Reticulophagy
2007
·
Ezgi Tasdemir
, M. Chiara Maiuri
, et al.
·
Cell Cycle
·
125
PDF
S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth
2018
·
Patrick Casara
, James Davidson
, et al.
·
Oncotarget
·
119
PDF
Discovery of S64315, a Potent and Selective Mcl-1 Inhibitor
2020
·
Zoltan Szlavik
, Marton Csekei
, et al.
·
Journal of Medicinal Chemistry
·
118
Various mechanisms cause RET-mediated signaling defects in Hirschsprung's disease.
1998
·
A Pelet
, O Geneste
, et al.
·
Journal of Clinical Investigation
·
102
Oncogenic activation of RET by two distinct FMTC mutations affecting the tyrosine kinase domain
1997
·
Andrea Pasini
, Olivier Geneste
, et al.
·
Oncogene
·
100
Comparison of pulmonary DNA adduct levels, measured by 32P-postlabelling and aryl hydrocarbon hydroxylase activity in lung parenchyma of smokers and ex-smokers
1991
·
O. Geneste
, A.-M. Camus
, et al.
·
Carcinogenesis
·
81
Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular Activity
2019
·
Zoltan Szlávik
, Levente Ondi
, et al.
·
Journal of Medicinal Chemistry
·
79
Establishing Drug Discovery and Identification of Hit Series for the Anti-apoptotic Proteins, Bcl-2 and Mcl-1
2019
·
James B. Murray
, James Davidson
, et al.
·
ACS Omega
·
77
Shooting at survivors: Bcl-2 family members as drug targets for cancer
2003
·
Philippe Juin
, Olivier Geneste
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
·
67
PDF
Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signalling effectors to a multifunctional docking site
1999
·
O Geneste
·
Human Molecular Genetics
·
58
Targeting Bcl-2/Bcl-XL Induces Antitumor Activity in Uveal Melanoma Patient-Derived Xenografts
2014
·
Fariba Némati
, Catherine de Montrion
, et al.
·
PLoS ONE
·
51
PDF
Cytochrome P450 2a of nasal epithelium: Regulation and role in carcinogen metabolism
1995
·
Jean‐Claude Béréziat
, Francoise Raffalli
, et al.
·
Molecular Carcinogenesis
·
49
Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer
2014
·
Y Loriot
, P Mordant
, et al.
·
Cell Death and Disease
·
47
PDF
Show more works
View as search
Works count:
77
Citation count:
5,874
H-index:
31
I10-index:
40
Year
Topic
Type